Tower Research Capital (TRC)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-157,033
| Closed | -$8.24M | – | 5652 |
|
|
2020
Q3 | $8.24M | Buy |
157,033
+142,927
| +1,013% | +$7.5M | 0.09% | 37 |
|
|
2020
Q2 | $469K | Buy |
+14,106
| New | +$469K | 0.02% | 1090 |
|
|
2019
Q4 | – | Sell |
-1,216
| Closed | -$16K | – | 4789 |
|
|
2019
Q3 | $16K | Sell |
1,216
-404
| -25% | -$5.32K | ﹤0.01% | 2650 |
|
|
2019
Q2 | $20K | Buy |
+1,620
| New | +$20K | ﹤0.01% | 2201 |
|
|
2018
Q3 | – | Sell |
-2,039
| Closed | -$41K | – | 4482 |
|
|
2018
Q2 | $41K | Buy |
+2,039
| New | +$41K | ﹤0.01% | 1956 |
|
|
2017
Q2 | – | Sell |
-1,300
| Closed | -$17K | – | 3895 |
|
|
2017
Q1 | $17K | Buy |
1,300
+1,123
| +634% | +$14.7K | ﹤0.01% | 1411 |
|
|
2016
Q4 | $3K | Buy |
177
+50
| +39% | +$847 | ﹤0.01% | 3329 |
|
|
2016
Q3 | $1K | Sell |
127
-473
| -79% | -$3.72K | ﹤0.01% | 3440 |
|
|
2016
Q2 | $6K | Buy |
600
+278
| +86% | +$2.78K | ﹤0.01% | 3314 |
|
|
2016
Q1 | $3K | Buy |
322
+221
| +219% | +$2.06K | ﹤0.01% | 3219 |
|
|
2015
Q4 | $1K | Buy |
+101
| New | +$1K | ﹤0.01% | 4249 |
|
|
2015
Q3 | – | Sell |
-5,070
| Closed | -$116K | – | 5161 |
|
|
2015
Q2 | $116K | Sell |
5,070
-2,012
| -28% | -$46K | 0.01% | 687 |
|
|
2015
Q1 | $108K | Buy |
7,082
+6,659
| +1,574% | +$102K | 0.01% | 822 |
|
|
2014
Q4 | $5K | Sell |
423
-553
| -57% | -$6.54K | ﹤0.01% | 2772 |
|
|
2014
Q3 | $11K | Buy |
+976
| New | +$11K | ﹤0.01% | 2778 |
|
|
2014
Q2 | – | Sell |
-745
| Closed | -$9K | – | 4920 |
|
|
2014
Q1 | $9K | Buy |
745
+9
| +1% | +$109 | ﹤0.01% | 2746 |
|
|
2013
Q4 | $13K | Buy |
+736
| New | +$13K | ﹤0.01% | 2769 |
|
|
2013
Q3 | – | Sell |
-1,223
| Closed | -$18K | – | 4975 |
|
|
2013
Q2 | $18K | Buy |
+1,223
| New | +$18K | ﹤0.01% | 1834 |
|